Profound Medical Corp. — Proxy Solicitation & Information Statement 2026

Apr 21, 2026

PROFOUND MEDICAL CORP.

National Instrument 54-101
COMMUNICATION WITH BENEFICIAL OWNERS OF SECURITIES OF A
REPORTING ISSUER

Date: April 20, 2026

TO:
Ontario Securities Commission
British Columbia Securities Commission
Alberta Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
Manitoba Securities Commission
Autorité des marchés financiers
Financial and Consumer Services Commission - New Brunswick
Nova Scotia Securities Commission
Financial and Consumer Services Division - Prince Edward Island
Office of the Superintendent of Securities Services - Newfoundland and Labrador
Office of the Yukon Superintendent of Securities
Office of the Superintendent of Securities - Northwest Territories
Office of the Superintendent of Securities - Nunavut

RE: Meeting of the shareholders of Profound Medical Corp. to be held on May 13, 2026
(the "Meeting")

I, Rashed Dewan, the Chief Financial Officer of Profound Medical Corp. hereby certify that:

(a) arrangements have been made to have proxy related materials for the Meeting sent in compliance with National Instrument 54-101 (the "Instrument"), to all beneficial owners at least 21 days before the date fixed for the Meeting;
(b) arrangements have been made to carry out all of the requirements of the Instrument in addition to those described in subparagraph (a); and
(c) Profound Medical Corp. is relying on section 2.20 of the Instrument to abridge the time prescribed in subsections 2.2(1) and 2.5(1) of the Instrument.

PROFOUND MEDICAL CORP.

Per: (Signed) "Rashed Dewan"
Rashed Dewan
Chief Financial Officer